Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129719) titled 'Efficacy and safety of pituitrin for pulmonary tuberculosis-associated hemoptysis: a multicenter retrospective cohort study' on Aug. 9.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The Third People's Hospital of Shenzhen
Condition:
Pulmonary tuberculosis-associated hemoptysis
R04.2
A15-A19
Intervention:
Early pituitrin use group (Use of pituitrin within 12 hours after the index hemoptysis event):None
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2024-03-11
Target Sample Size: Early pituitrin use group (Use of pituitrin within 12 hours after the in...